Automated And Closed CTS DynaCellect Magnetic Separation System Delivers Target T Cell Isolation And Magnetic Bead Removal At High Efficiency

Successful commercial manufacturing of T cell therapies is essential to assuring the timely delivery of efficacious products to patients. However, the industry currently faces several key barriers that limit the capability to deliver the required volume of high-quality product for autologous therapies and developing allogeneic applications. Evaluate and explore a cell processing platform for T cell isolation and activation using magnetic beads that is supporting the cell therapy industry through these challenges.